Literature DB >> 28321846

Molecular analysis of patients with aniridia in Russian Federation broadens the spectrum of PAX6 mutations.

T A Vasilyeva1, A A Voskresenskaya2, B Käsmann-Kellner3, O V Khlebnikova1, N A Pozdeyeva2, G M Bayazutdinova1, S I Kutsev1,4, E K Ginter1, E V Semina5, A V Marakhonov1,6, R A Zinchenko1,4.   

Abstract

Congenital aniridia is a severe autosomal dominant congenital panocular disorder, mainly associated with pathogenic variants in the PAX6 gene. The objective of the study was to investigate the mutational and clinical spectra of congenital aniridia in a cohort of 117 patients from Russia. Each patient underwent detailed ophthalmological examination. From 91 unrelated families, 110 patients were diagnosed with congenital aniridia and 7 with WAGR syndrome (Wilms tumor, Aniridia, Genitourinary anomalies, and mental Retardation syndrome). The clinical presentation in aniridia patients varied from the complete bilateral absence of the iris (75.5%) to partial aniridia or iris hypoplasia (24.5%). Additional ocular abnormalities were consistent with previous reports. In our cohort, we saw a previously not described high percentage of patients (45%) who showed non-ocular phenotypes. Prevalence of deletions coherent with WAGR syndrome appeared to be 19.4% out of sporadic patients. Among the other aniridia cases, PAX6 deletions were identified in 18 probands, and small intragenic changes were detected in 58 probands with 27 of these mutations being novel and 21 previously reported. In 3 families mosaic mutation was transmitted from a subtly affected parent. Therefore, PAX6 mutations explained 96.7% of aniridia phenotypes in this study with only 3 of 91 probands lacking pathogenic variants in the gene.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990CNS involvement; zzm321990OMIM #106210; zzm321990PAX6 syndrome; de novo mutations; iris hypoplasia; large deletions; non-ocular complications; novel mutations

Mesh:

Substances:

Year:  2017        PMID: 28321846     DOI: 10.1111/cge.13019

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  14 in total

1.  Implication of non-coding PAX6 mutations in aniridia.

Authors:  Julie Plaisancié; M Tarilonte; P Ramos; C Jeanton-Scaramouche; V Gaston; H Dollfus; D Aguilera; J Kaplan; L Fares-Taie; F Blanco-Kelly; C Villaverde; C Francannet; A Goldenberg; I Arroyo; J M Rozet; C Ayuso; N Chassaing; P Calvas; M Corton
Journal:  Hum Genet       Date:  2018-10-05       Impact factor: 4.132

2.  Functional reassessment of PAX6 single nucleotide variants by in vitro splicing assay.

Authors:  Alexandra Yu Filatova; Tatiana A Vasilyeva; Andrey V Marakhonov; Anna A Voskresenskaya; Rena A Zinchenko; Mikhail Yu Skoblov
Journal:  Eur J Hum Genet       Date:  2018-10-12       Impact factor: 4.246

Review 3.  Relative Frequencies of PAX6 Mutational Events in a Russian Cohort of Aniridia Patients in Comparison with the World's Population and the Human Genome.

Authors:  Tatyana A Vasilyeva; Andrey V Marakhonov; Sergey I Kutsev; Rena A Zinchenko
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

4.  Preferentially Paternal Origin of De Novo 11p13 Chromosome Deletions Revealed in Patients with Congenital Aniridia and WAGR Syndrome.

Authors:  Tatyana A Vasilyeva; Andrey V Marakhonov; Natella V Sukhanova; Sergey I Kutsev; Rena A Zinchenko
Journal:  Genes (Basel)       Date:  2020-07-17       Impact factor: 4.096

5.  Morphometric analysis of the lens in human aniridia and mouse Small eye.

Authors:  Anna Voskresenskaya; Nadezhda Pozdeyeva; Yevgeniy Batkov; Tatyana Vasilyeva; Andrey Marakhonov; Richard A West; Jeffrey L Caplan; Ales Cvekl; Yan Wang; Melinda K Duncan
Journal:  Exp Eye Res       Date:  2020-11-26       Impact factor: 3.467

6.  Molecular analysis of Cypriot families with aniridia reveals a novel PAX6 mutation.

Authors:  Andreas Syrimis; Nayia Nicolaou; Angelos Alexandrou; Ioannis Papaevripidou; Michael Nicolaou; Eleni Loukianou; Carolina Sismani; Stavros Malas; Violetta Christophidou-Anastasiadou; George A Tanteles
Journal:  Mol Med Rep       Date:  2018-06-05       Impact factor: 2.952

7.  Expanding the phenotype of CRYAA nucleotide variants to a complex presentation of anterior segment dysgenesis.

Authors:  Andrey V Marakhonov; Anna A Voskresenskaya; Maria Jose Ballesta; Fedor A Konovalov; Tatyana A Vasilyeva; Fiona Blanco-Kelly; Nadezhda A Pozdeyeva; Vitaly V Kadyshev; Vanesa López-González; Encarna Guillen; Carmen Ayuso; Rena A Zinchenko; Marta Corton
Journal:  Orphanet J Rare Dis       Date:  2020-08-13       Impact factor: 4.123

8.  Parental Mosaicism in PAX6 Causes Intra-Familial Variability: Implications for Genetic Counseling of Congenital Aniridia and Microphthalmia.

Authors:  María Tarilonte; Matías Morín; Patricia Ramos; Marta Galdós; Fiona Blanco-Kelly; Cristina Villaverde; Dolores Rey-Zamora; Gema Rebolleda; Francisco J Muñoz-Negrete; Saoud Tahsin-Swafiri; Blanca Gener; Miguel-Angel Moreno-Pelayo; Carmen Ayuso; Manuela Villamar; Marta Corton
Journal:  Front Genet       Date:  2018-10-17       Impact factor: 4.599

9.  Extension of the mutation spectrum of PAX6 from three Chinese congenital aniridia families and identification of male gonadal mosaicism.

Authors:  Zhouxian Bai; Xiangdong Kong
Journal:  Mol Genet Genomic Med       Date:  2018-10-17       Impact factor: 2.183

10.  Epistasis between Pax6Sey and genetic background reinforces the value of defined hybrid mouse models for therapeutic trials.

Authors:  Jack W Hickmott; Uvini Gunawardane; Kimberly Jensen; Andrea J Korecki; Elizabeth M Simpson
Journal:  Gene Ther       Date:  2018-09-26       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.